The Relationship Among rSO2, MAP, et al by Near-Infrared Spectroscopy in Endovascular Neurosurgery

The Relationship Among rSO2, MAP,CAM Value, Vital Organ Disfunction and the Outcome of Patients After Operation by Near-Infrared Spectroscopy in Endovascular Neurosurgery

record,describe and discuss the relationship among rSO2, MAP,CAM value, vital organ disfunction and the outcome of patients after operation by Near-Infrared Spectroscopy in Endovascular Neurosurgery

Study Overview

Detailed Description

record,describe and discuss the relationship among rSO2, MAP,CAM value, vital organ disfunction and the outcome of patients after operation using Near-Infrared Spectroscopy in Endovascular Neurosurgery meanwhile detect the Brain oxygen supply and function monitoring using noninvasive Near-Infrared Spectroscopy in Endovascular Neurosurgery.

Study Type

Observational

Enrollment (Actual)

43

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 76 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Scheduled to undergoing Endovascular Neurosurgery

Description

Inclusion Criteria:

  • American Society of Anesthesiology (ASA) class I~Ⅲ, ranging in age from 18 to 80 years

Exclusion Criteria:

  • ASA>Ⅳ
  • Non-cooperators
  • Morbid obesity (BMI>35kg/m2)
  • Preoperative hyperresponsiveness airway and gastro-esophageal reflux
  • The existence of the state or a diagnosis of dementia, delirium, depression, cognitive dysfunction before surgery were also excluded

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
there is relationship between rSO2 and MAP during neurosurgery
Time Frame: 2 month
2 month
there is relatinship between rSO2 and CAM values
Time Frame: 2 month
2 month
vital organ disfunction related to rSO2 and bad outcome of the patients
Time Frame: 3 month
3 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2015

Primary Completion (Actual)

January 1, 2017

Study Completion (Actual)

May 1, 2017

Study Registration Dates

First Submitted

January 24, 2015

First Submitted That Met QC Criteria

February 1, 2015

First Posted (Estimate)

February 5, 2015

Study Record Updates

Last Update Posted (Actual)

August 7, 2018

Last Update Submitted That Met QC Criteria

August 4, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 0810-758

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Near-Infrared Spectroscopy in Endovascular Neurosurgery

Subscribe